A. Lila, V. I. Mazurov, E. Nasonov, S. Lukyanov, T. Dubinina, I. Z. Gaidukova, A. Klimenko, S. A. Lapshina, G. V. Lukina, M. A. Korolev, R. Dreval, P. I. Pchelnikova, N. V. Shatalova
{"title":"专家委员会关于 \"治疗轴性脊柱关节炎的新方法 \"的决议","authors":"A. Lila, V. I. Mazurov, E. Nasonov, S. Lukyanov, T. Dubinina, I. Z. Gaidukova, A. Klimenko, S. A. Lapshina, G. V. Lukina, M. A. Korolev, R. Dreval, P. I. Pchelnikova, N. V. Shatalova","doi":"10.14412/1996-7012-2024-3-134-139","DOIUrl":null,"url":null,"abstract":" On 30 May, 2024, an expert meeting was held to update the approaches for the treatment of axial spondyloarthritis (axSpA). A new approach to the treatment of axSpA was considered, which consists of depleting autoreactive TRBV9+ T- lymphocytes by introducing a monoclonal antibody – the drug seniprutug. The value of the drug seniprutug in the treatment of the disease was discussed and key aspects for the incorporation of the drug seniprutug into real-world clinical rheumatological practice were agreed.","PeriodicalId":18651,"journal":{"name":"Modern Rheumatology Journal","volume":"4 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Resolution of the Expert Council “New approaches to the treatment of axial spondyloarthritis”\",\"authors\":\"A. Lila, V. I. Mazurov, E. Nasonov, S. Lukyanov, T. Dubinina, I. Z. Gaidukova, A. Klimenko, S. A. Lapshina, G. V. Lukina, M. A. Korolev, R. Dreval, P. I. Pchelnikova, N. V. Shatalova\",\"doi\":\"10.14412/1996-7012-2024-3-134-139\",\"DOIUrl\":null,\"url\":null,\"abstract\":\" On 30 May, 2024, an expert meeting was held to update the approaches for the treatment of axial spondyloarthritis (axSpA). A new approach to the treatment of axSpA was considered, which consists of depleting autoreactive TRBV9+ T- lymphocytes by introducing a monoclonal antibody – the drug seniprutug. The value of the drug seniprutug in the treatment of the disease was discussed and key aspects for the incorporation of the drug seniprutug into real-world clinical rheumatological practice were agreed.\",\"PeriodicalId\":18651,\"journal\":{\"name\":\"Modern Rheumatology Journal\",\"volume\":\"4 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Modern Rheumatology Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14412/1996-7012-2024-3-134-139\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern Rheumatology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14412/1996-7012-2024-3-134-139","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Resolution of the Expert Council “New approaches to the treatment of axial spondyloarthritis”
On 30 May, 2024, an expert meeting was held to update the approaches for the treatment of axial spondyloarthritis (axSpA). A new approach to the treatment of axSpA was considered, which consists of depleting autoreactive TRBV9+ T- lymphocytes by introducing a monoclonal antibody – the drug seniprutug. The value of the drug seniprutug in the treatment of the disease was discussed and key aspects for the incorporation of the drug seniprutug into real-world clinical rheumatological practice were agreed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
